🔎 Trials Near Me

Utama › Sarkoma Tisu Lembut › Massachusetts › Boston

Kajian klinikal Sarkoma Tisu Lembut di Boston, MA

18 kajian untuk Sarkoma Tisu Lembut sedang mencari peserta di lokasi dalam dan sekitar Boston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Mengambil peserta
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Mengambil pesertaFasa 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute., Boston
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04094610

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06641908

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05732831

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06644755

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Mengambil pesertaFasa 1
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT05711615

Serial MRI Scans During Radiation Therapy

Mengambil peserta
  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT04188535

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

Mengambil peserta
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 15 hingga 39 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07662239

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06975293

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Sehingga umur 30 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Mengambil pesertaKajian pemerhatian
  • Brigham and Women's Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT07377747

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Mengambil pesertaKajian pemerhatian
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT07675967

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital,, Boston
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Video Education With Result Dependent dIsclosure

Mengambil peserta
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT05225428

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Mengambil pesertaFasa 1/2
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Umur 12 hingga 49 · Semua jantina · Dikemas kini 19 Feb 2026 · NCT06709495

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Okt 2025 · NCT04370587

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Mengambil pesertaKajian pemerhatian
  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Feb 2019 · NCT03838718

Kajian Sarkoma Tisu Lembut di bandar lain

Kajian lain di Boston

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.